The American Society of Health-System Pharmacies is speaking out against Johnson & Johnson’s plan to drop upfront discounts for some 340B drugs.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Pharmacists slam J&J's plan to end upfront 340B discounts
